Congenital aniridia and rare iris diseases are very disabling genetic conditions with a risk of blindness for which there is still no cure today. It is for these reasons that, since its creation in 2005, GÊNIRIS, the only French-speaking patient association dedicated to these diseases, acts to promote research on congenital aniridia and rare iris diseases and, since 2013, funds research on these pathologies.
In 2022, the Board of Directors and the Medical and Scientific Council of GÊNIRIS will launch a call for research projects of 60,000 euros for all 3 research projects.
More information 👉🏽 https://www.geniris.fr/actualite-429-document-appel-a-projets-2022.html
Text of the call for projects👉🏽https://www.geniris.fr/uploaded/recherche/20220406-aap2022-recherche-cms-geniris.pdf
Deadline for submission: June 05, 2022 at midnight